Literature DB >> 31100635

The evolution of Great Apes has shaped the functional enhancers' landscape in human embryonic stem cells.

Gennadi Glinsky1, Tahsin Stefan Barakat2.   

Abstract

High-throughput functional assays of enhancer activity have recently enabled the genome-scale definition of molecular, structural, and biochemical features of these genomic regulatory regions. To infer the evolutionary origin of DNA sequences operating as functional enhancers in human embryonic stem cells (hESC), we examined the patterns of evolutionary conservation and divergence in the genome-wide functional enhancers' landscape of hESC. We show that a prominent majority (up to 94%) of DNA sequences identified in hESC as functional enhancers are conserved in humans and our closest evolutionary relatives, Chimpanzee and Bonobo. More than 91% of functional enhancers that are highly conserved in both Chimpanzee and Bonobo, are conserved among other Great Apes and >75% are conserved in the Rhesus genome. In striking contrast, <5% of DNA sequences operating in hESC as functional enhancers are conserved in rodents. Conserved in primates enhancers' sequences are complemented by 1619 sequences of enhancers that are specific to humans. Enhancers that harbor human-specific sequences appear enriched among the invariant enhancer module maintaining activity in different pluripotent states and these regions are associated with pluripotency- and embryonic-lineage-related genes. However, functional enhancers make up only a minority of all conserved in primates or human-specific transcription factor binding sites. Our analyses revealed that sequences that are conserved during ~8 million years of primate evolution dominate the genomic landscape of functional enhancers in both primed and naïve hESC. Collectively, these observations revealed thousands of evolutionarily conserved sequences that function as a core regulatory network in human embryonic stem cells which has recently undergone further extension after divergence of modern humans from our closest relatives, Chimpanzee and Bonobo.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31100635     DOI: 10.1016/j.scr.2019.101456

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  12 in total

1.  Anticancer Efficacy and Mechanisms of a Dual Targeting of Norepinephrine Transporter and Thyrointegrin αvβ3 Antagonist in Neuroblastoma.

Authors:  Kavitha Godugu; Ozlem O Karakus; Kazutoshi Fujioka; Gennadi V Glinsky; Shaker A Mousa
Journal:  J Cancer       Date:  2022-05-16       Impact factor: 4.478

2.  Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.

Authors:  Gennadi V Glinsky
Journal:  Biomedicines       Date:  2020-05-21

3.  Beyond the Exome: The Non-coding Genome and Enhancers in Neurodevelopmental Disorders and Malformations of Cortical Development.

Authors:  Elena Perenthaler; Soheil Yousefi; Eva Niggl; Tahsin Stefan Barakat
Journal:  Front Cell Neurosci       Date:  2019-07-31       Impact factor: 5.505

4.  LINE retrotransposons characterize mammalian tissue-specific and evolutionarily dynamic regulatory regions.

Authors:  Maša Roller; Ericca Stamper; Diego Villar; Osagie Izuogu; Fergal Martin; Aisling M Redmond; Raghavendra Ramachanderan; Louise Harewood; Duncan T Odom; Paul Flicek
Journal:  Genome Biol       Date:  2021-02-18       Impact factor: 13.583

5.  Genomics-Guided Drawing of Molecular and Pathophysiological Components of Malignant Regulatory Signatures Reveals a Pivotal Role in Human Diseases of Stem Cell-Associated Retroviral Sequences and Functionally-Active hESC Enhancers.

Authors:  Gennadi V Glinsky
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

6.  Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance.

Authors:  Ruizhi Deng; Kristina Lanko; Eva Medico Salsench; Anita Nikoncuk; Soheil Yousefi; Herma C van der Linde; Elena Perenthaler; Tjakko J van Ham; Eskeatnaf Mulugeta; Tahsin Stefan Barakat
Journal:  Genome Med       Date:  2021-10-19       Impact factor: 11.117

7.  Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.

Authors:  Noureldien H E Darwish; Gennadi V Glinsky; Thangirala Sudha; Shaker A Mousa
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

8.  Endogenous retroviruses co-opted as divergently transcribed regulatory elements shape the regulatory landscape of embryonic stem cells.

Authors:  Stylianos Bakoulis; Robert Krautz; Nicolas Alcaraz; Marco Salvatore; Robin Andersson
Journal:  Nucleic Acids Res       Date:  2022-02-28       Impact factor: 16.971

9.  Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.

Authors:  Gennadi V Glinsky; Kavitha Godugu; Thangirala Sudha; Mehdi Rajabi; Sridar V Chittur; Aleck A Hercbergs; Shaker A Mousa; Paul J Davis
Journal:  Metabolites       Date:  2022-04-04

10.  Evolution of mouse circadian enhancers from transposable elements.

Authors:  Julius Judd; Hayley Sanderson; Cédric Feschotte
Journal:  Genome Biol       Date:  2021-06-29       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.